Streetbeat News

Revenues

RYTM

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) announced the Italian Medicine Agency (AIFA) approved reimbursement for IMCIVREE (setmelanotide) for treating obesity and controlling hunger in Bardet-Biedl syndrome (BBS) patients in Italy. This marks the first and only treatment option authorized in the European Union for this rare neuroendocrine disease, with Rhythm aiming to expand access across Europe. BBS is characterized by severe obesity and hyperphagia, among other symptoms, with an estimated 200 patients identified in Italy.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:25 pm

OGEN

Oragenics, Inc. (OGEN) announced the expiration of its investment banking engagement agreement, choosing not to extend it due to market conditions. The company is developing ONP-002, a neurosteroid for treating mild Traumatic Brain Injury (mTBI), showing promising preclinical results. The global market for concussion treatment is expected to grow from $6.9 billion in 2020 to $8.9 billion by 2027.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:19 pm

MIDD

The Middleby Corporation (NASDAQ:MIDD) has acquired GBT GmbH Bakery Technology, a German company specializing in industrial baking and bread lines with annual revenues of approximately €10 million. This acquisition enhances Middleby's bakery portfolio, strengthens its European presence, and is expected to benefit from synergies and Middleby's established customer channels.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:18 pm

CVS

During a conference call, a CVS Health executive mentioned an increase in Q4 costs due to seasonal immunizations, including expenses for the newly launched RSV vaccine. The company is adopting a cautious stance on the 2024 outlook for Medicare Advantage utilization, pending clarity on industry-wide trends.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:18 pm

NVEI

Nuvei Corporation (NASDAQ:NVEI) announces the global rollout of its enhanced omnichannel payments solution, now available outside North America. This solution unifies online and offline payments, offering businesses from various sectors like retail and hospitality, a seamless checkout experience tailored for each channel. It combines card-present and card-not-present technology for eCommerce, mobile, and in-store transactions, enabling unified payment acceptance. Additional features include comprehensive analytics, streamlined operations through a common API, and flexible retail payments hardware options. Nuvei's global reach and local acquiring capabilities in 50 countries, along with connectivity to 680 alternative payment methods, support international market expansion.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:17 pm

BAC

Bank of America's Q4 2023 Participant Pulse report reveals a 15% increase in average 401(k) account balances and an 11% increase in Health Savings Account balances. The report, analyzing over 4 million participants, shows a doubling in the percentage of participants who increased their 401(k) contributions in Q4. Additionally, fewer participants took loans from their 401(k) plans, and the average loan amount decreased. The report also highlights that Millennials are saving a higher percentage of their HSA contributions compared to other generations.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:17 pm

CDAY

Dayforce projects Q1 2024 revenue to be between $424M-$427M, slightly below the $427.81M estimate, and forecasts FY24 revenue of $1.72B-$1.73B, under the $1.74B estimate. The company anticipates a 14%-15% year-over-year revenue increase for Q1 and a 14% increase for FY24, with Dayforce recurring revenue expected to grow 20%-22% in Q1 and 20%-21% for the full year. Adjusted EBITDA is projected at $123M-$126M for Q1 and $480M-$495M for FY24, reflecting investments in global expansion and the Dayforce platform scaling.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:12 pm

RSVR

Reservoir Media forecasts its FY24 revenue to be between $140M-$142M, surpassing the estimated $135.663M.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:09 pm

REYN

Reynolds Consumer Products projects its Q1 2024 revenue to be between $795M and $820M, which is below the estimated $854.337M.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:07 pm

TTMI

TTM Technologies forecasts Q1 2024 revenue to be between $530M-$570M, compared to analysts' expectations of $555.59M. Adjusted EPS is expected to be $0.24-$0.30, against an estimate of $0.27.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:04 pm